5q- Syndrome

Search Trials
A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies
Status:
Completed
Last Changed:
Feb 11, 2015
First Changed:
Jun 23, 2006
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
cyclophosphamidefludarabine phosphatecyclosporinemycophenolate mofetilex-vivo umbilical cord blood expansiondouble-unit umbilical cord blood transplantationbiopsyimmunologic techniquediagnostic laboratory biomarker analysis
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
Status:
Completed
Last Changed:
May 17, 2017
First Changed:
Jan 27, 2003
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
cyclophosphamidefludarabine phosphatetacrolimusmycophenolate mofetilpolymerase chain reactionfluorescence in situ hybridizationpolymorphism analysisgene expression analysistotal-body irradiationallogeneic bone marrow transplantationallogeneic hematopoietic stem cell transplantation
Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies
Status:
Completed
Last Changed:
Apr 6, 2017
First Changed:
Aug 5, 2010
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
umbilical cord blood transplantationfludarabine phosphatecyclophosphamideex vivo-expanded cord blood progenitor cell infusiontotal-body irradiationcyclosporinemycophenolate mofetillaboratory biomarker analysis
Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Feb 19, 2018
First Changed:
Oct 15, 2012
Disease(s):
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Intervention(s):
decitabinefludarabine phosphatebusulfancyclophosphamidetacrolimusmycophenolate mofetilfilgrastimtotal-body irradiationallogeneic bone marrow transplantationlaboratory biomarker analysis
Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies
Status:
Active, not recruiting
Last Changed:
Jun 20, 2018
First Changed:
Jan 27, 2003
Disease(s):
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Intervention(s):
alemtuzumabfludarabine phosphatetotal-body irradiationallogeneic hematopoietic stem cell transplantationperipheral blood stem cell transplantationmycophenolate mofetilcyclosporine

Connect. Empower. Inspire.